Rijken D C, Otter M, Kuiper J, van Berkel T J
Gaubius Institute TNO, Leiden, The Netherlands.
Thromb Res Suppl. 1990;10:63-71. doi: 10.1016/0049-3848(90)90379-q.
Tissue-type plasminogen activator (t-PA) has a short half-life in the circulation because the enzyme is rapidly cleared by the liver. This short review summarizes recent literature concerning mechanisms of uptake and degradation of t-PA in the liver. In vivo studies in rats show that degradation takes place via a lysosomal pathway. Saturation of the uptake system at high t-PA concentrations suggests a receptor-mediated mechanism. Competition experiments with various glycoproteins indicate that the asialoglycoprotein receptor is not involved, but they point to a role for the mannose receptor, which recognizes t-PA via its high mannose-type oligosaccharide on the first kringle domain. Both in vivo and in vitro studies with isolated liver cells demonstrate that parenchymal cells, as well as liver endothelial cells, are involved in the clearance of t-PA. Parenchymal cells, as the hepatoma cell line Hep G2, endocytose t-PA via a still unknown, possibly t-PA specific receptor, while liver endothelial cells catabolize t-PA via the mannose receptor.
组织型纤溶酶原激活剂(t-PA)在循环系统中的半衰期较短,因为该酶会被肝脏迅速清除。这篇简短综述总结了近期有关肝脏中t-PA摄取和降解机制的文献。对大鼠的体内研究表明,降解通过溶酶体途径进行。在高t-PA浓度下摄取系统的饱和表明存在受体介导的机制。与各种糖蛋白的竞争实验表明,去唾液酸糖蛋白受体不参与其中,但这些实验指出了甘露糖受体的作用,该受体通过其在第一个kringle结构域上的高甘露糖型寡糖识别t-PA。对分离的肝细胞进行的体内和体外研究均表明,实质细胞以及肝内皮细胞都参与了t-PA的清除。实质细胞,如肝癌细胞系Hep G2,通过一种仍未知的、可能是t-PA特异性受体对t-PA进行内吞,而肝内皮细胞则通过甘露糖受体分解代谢t-PA。